Home › Primary Effusion Lymphoma › Washington
Primary Effusion Lymphoma clinical trials in Washington, DC
3 studies for Primary Effusion Lymphoma are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Natural History of KSHV-Associated Multicentric Castleman s Disease
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.